Menu ☰

AOD-9604 Research & Care Discussion

Weight management & metabolic research

Research & evidence

Searching for AOD-9604?
Start with your weight-management goals.

You want progress that fits real life. Explore the research behind this growth-hormone fragment, compare the claims with the evidence, and discuss established weight-management options with a clinician.

Estimated research-market price · not a treatment offerEst. $41per 5 mg laboratory research vialResearch-material price context only. Seine Bio does not sell powders for self-reconstitution or offer this compound. See prices & details →

Educational research topic · No AOD-9604 treatment is offered on this page.

Clear prices. A clearer next step.

Explore the research. Understand the price context.

The research-market figure below is educational context. Neither a free account nor optional membership purchases access to this compound.

Estimated research-market price · not a treatment offer

AOD 9604 · research market context

Est. $41per 5 mg laboratory research vial

Single selected public supplier listing. This is research-market context, not a clinical drug quote, treatment cost or purchase offer.

Research-material market context only. Seine Bio does not sell lyophilized powders for self-reconstitution or offer this research compound. This figure does not price a finished clinical product; any lawful treatment requires its own quote. Membership does not provide the named investigational compound.

Discuss my care options
Price sources & what is included

Public research-material listings reviewed October 7, 2026. Prices and stock can change; taxes and shipping may be additional. These source links document laboratory listings, not patient-use products, supplier quality or lawful clinical availability.

Core Peptides public research catalog

Optional product-savings membership

Start with a personal care conversation.

$20Per month · Cancel anytime

  • 2% off products; therapy services and membership dues excluded
  • Free two-business-day shipping after dispatch on $100+ physical-product orders before discounts and taxes in the contiguous United States
  • Cancel anytime to stop future membership renewals

Medication, labs, products and additional treatment cost extra. Care is subject to clinical fit and availability. Membership does not guarantee a prescription, named peptide or research enrollment.

Create a free account ↗
Your goal guides the conversation. An assessment may lead to a prescription, an appropriate nonprescription product, further investigation or a referral. A different option may be recommended. Gummies, oral supplements, topical cosmetics and injections have different ingredients, evidence and uses. Your care team confirms the actual product, suitability, availability and separate costs before you choose.

Understand the topic

AOD-9604.
A clearer overview.

Start with the research. Keep your goals in view.

Current status

Research topic. AOD-9604 is not an FDA-approved weight-management medicine. Seine Bio does not offer AOD-9604 treatment through this page.

01 / THE BIOLOGY

What makes it interesting.

AOD-9604 is a synthetic sixteen-amino-acid peptide based on the C-terminal fragment of human growth hormone, with an additional tyrosine. It was developed to investigate effects on fat metabolism separately from some actions of the full hormone. A fragment is not interchangeable with growth hormone or an approved weight-management drug.

02 / THE HISTORY

The story behind the interest.

AOD-9604 entered obesity drug-development research before the current online peptide boom. Published reports discuss oral and intravenous studies. Its later appearance in injectable wellness marketing adds a different route and formulation question; historical research cannot simply validate that use.

Evidence before expectations

Read beyond
the headline.

A useful research discussion includes the study design, the population and the outcome measured.

Read the original sources

A 2013 publication summarized safety and tolerability data from several human studies using oral and intravenous exposure. A safety-focused report is not evidence of meaningful weight loss, and it cannot establish safety for a different route.

FDA’s 2024 evaluation found insufficient evidence of effectiveness for obesity and identified gaps in the proposed subcutaneous and topical uses. That distinction matters when websites describe the compound simply as a fat-burning peptide.

Your care discussion can compare established options, expected benefits, monitoring and costs. Interest in an emerging compound can be a starting point, but the plan should fit your medical history and the treatments that are appropriate and available.

Findings for one condition, route or preparation do not establish the same result for another.
The evidence at a glance
Research settingWhat the record showsWhat it does not establish
Historical human studiesA publication summarized oral and intravenous safety data.Does not establish safety for subcutaneous products.
Obesity evidence reviewFDA evaluated effectiveness and safety for proposed compounded uses.Does not support an approved weight-loss claim.
Clinical alternativesA clinician can assess established weight-management options.A consultation does not guarantee a particular prescription.

Understand the evidence

Understanding doses
and cycles.

A clear reference for your conversation with a clinician.

Research doses describe a specific study, not a treatment plan. Online popularity does not establish safety.

AOD-9604 · evidence at a glance
Preparation / contextDose referenceFrequencyDuration / cycleEvidence & source
AOD-9604Not established for this proposed wellness useNot establishedNo validated human on/off cycleEvidence limitations
An injectable fat-loss cycle is not established by the cited evidence.
Read the source

Swipe or scroll sideways to see every column. There is no universal peptide cycle. A published trial, a product label and an informal online protocol are different kinds of information.

Sources reviewed October 7, 2026. A dose listed here does not establish availability or suitability through Seine Bio.

Discuss my options

An honest view of uncertainty

Ask better questions.
Understand the concerns.

Missing safety information cannot be treated as proof that a product is safe.

Risks & concerns

What deserves attention.

  • Trials reported adverse events, including gastrointestinal symptoms; the investigators did not attribute serious events to treatment.
  • FDA also flags serious adverse events with uncertain causality and incomplete safety and product-characterization information.
  • An online growth-hormone-fragment claim does not establish long-term metabolic, reproductive or cancer safety.

A compound’s name, a purity claim or research-use labeling does not establish patient-ready quality, sterility or a reliable clinical outcome.

Regulatory context

Review is not an approval.

FDA evaluated AOD-9604 in December 2024. It appears in the current withdrawn-nomination table, rather than the July 2026 seven-substance agenda. A withdrawn nomination is not a drug approval.

Compounding review, permission to conduct research and approval of a finished drug are different decisions. This page is an invitation to learn and discuss appropriate care, not a statement that this compound can be supplied.

Check the official sources

The goal behind your search

A plan for your goals.
More than a trending compound.

Start with the changes you want: easier movement, improved habits, a healthier weight or support after repeated setbacks. Our team can explain the weight-management consultation path and the current options a clinician may consider, with clear costs and individual screening.

01

Share your goal.

Create a free account. Tell the team which care conversation interests you; keep sensitive health details for private clinical intake.

02

Understand your options.

The appropriate clinician can discuss the research, its limitations and established alternatives. Relevant research resources may be discussed when appropriate; eligibility and access are controlled by the study or sponsor.

03

Choose your next step.

Review suitability, available care and clear costs before deciding. A plan may involve established treatment, a referral or further assessment. No particular prescription or research access is guaranteed.

Good questions welcome

Make the next
step clearer.

You can be curious about research and still choose a practical care path available today.

Is AOD-9604 approved for weight loss?

No. It is not an FDA-approved obesity medicine. A research history, a clinician discussion or a compounding nomination does not change that status.

Are historical safety studies enough to validate injections?

No. The cited report involves oral and intravenous research. Different routes and preparations need their own supporting evidence and appropriate quality evaluation.

Can I ask about alternatives to AOD-9604?

Yes. Discuss your interest and your weight-management goals. A clinician can explain established options, including approved medicines when appropriate, as well as non-medication care.

Do I need to choose a medication before I inquire?

No. A free account starts the review process. Screening and an individual evaluation come before clinical decisions. Costs are explained before a payment decision.

A simple place to start

Bring your questions.
Explore your next step.

Create a free account to request review and manage purchases. Paid membership is optional. Clinical review and authorization still apply where required, and any separate service charges are shown before you agree to pay.

  • A free account with basic contact details
  • Screening and clear costs before payment
  • Established alternatives discussed when appropriate
Your goalAccount & screeningClinical discussion

An inquiry is not an application for guaranteed access to this compound. Membership does not include or guarantee experimental treatment. Any clinical care and costs will be explained separately.

MY NEXT STEPNo payment today

Please keep medical history, medications and sensitive personal details for private clinical intake.

Learn more

Read the sources.
Bring your questions.

Original research and official regulatory materials help put claims into context. Study links are educational and do not establish a treatment offer.

Reviewed October 7, 2026. Regulatory status and research records may change.

  1. 01FDA AOD-9604 effectiveness and safety briefing, December 2024
  2. 022013 human safety and tolerability publication
  3. 03FDA current safety and withdrawn nominations

Questions about AOD-9604?Start a care conversation

Start my inquiry

Clinical inquiries: age 18+. Research information does not imply treatment availability. Clinical decisions require an individual evaluation by an appropriate licensed clinician. An inquiry or membership does not guarantee a prescription, research enrollment or a specific outcome.

We do not provide emergency services. For immediate danger or a medical emergency, call 911. For a mental health crisis in the U.S., call or text 988.

Shopping Cart